TRENTON BAKER: Open Payments
NPI 1295106540 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 38 payments from 11 companies in 2025. Trend: 2023 $254 · 2024 $677 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $313 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $178 |
| Janssen Biotech, Inc. | 8 | $151 |
| Madrigal Pharmaceuticals | 4 | $118 |
| Aimmune Therapeutics, Inc. | 2 | $55 |
| Celltrion USA Inc. | 2 | $47 |
| Exact Sciences Corporation | 1 | $29 |
| Lilly USA, LLC | 1 | $28 |
| Ardelyx, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: TREMFYA, ENTYVIO, RINVOQ, REZDIFFRA, LINZESS, MAVYRET, VOWST, VEGZELMA.
Industry payments across WA — which companies pay providers there.
